Yoshikazu America and China (02453.HK) set up three partnerships with independent third parties to seek long-term strategic development opportunities
Gelonghui, April 26, 丨 US and China Jiahe (02453.HK) announced that in order to promote the company's strategic development and business operation needs, the company and an independent third party set up three partnerships to manage minority shares in the three subsidiaries (i.e. Shanghai Hospital, Shanghai Outpatient Department and Ningbo Jiahe) acquired by the independent third party as a general partner to seek strategic opportunities in line with the company's long-term development. The relevant details are as follows: On April 7, 2024, April 22, 2024, and April 7, 2024, the company and Lingbou Private Equity (independent third party) were established, respectively Joined the partnership Jiaxue Health,
Shanxi Installation (02520.HK) elected Yan Lei as shareholder representative supervisor
Gelonghui, April 26, 丨 Shanxi Installation (02520.HK) announced that on April 23, 2024, the company's board of supervisors received the resignation of Mr. Cao Haiyang, the company's shareholder representative supervisor. Due to changes in work, Mr. Cao resigned as the company's shareholder representative supervisor. According to the company's “Articles of Association”, Mr. Cao's resignation took effect when the company's new shareholders' representative supervisor was elected by the company's shareholders' meeting. The company held a board of supervisors meeting on April 26, 2024. The meeting elected Mr. Yan Lei as the company's shareholder representative supervisor. The term of office will take effect on the date of approval by the company's shareholders' meeting.
君聖泰醫藥-B:2023年報
荃信生物-B:2023年度報告
喜相逢集團:2023年報
知行汽車科技:2023 年度報告